Furthermore, it has been illustrated that a PD-1 inhibitor combined with albumin-bound paclitaxel is effective in metastatic tumors such as upper tract urothelial carcinoma and hypopharyngeal/laryngeal squamous cell carcinoma (18, 19). This evidence concerns the gene PDCD1 and laryngeal squamous cell carcinoma.